发明授权
- 专利标题： Substituted oxoazaheterocyclyl compounds
- 专利标题（中）： 取代的含氮杂环基化合物
-
申请号： US10628093申请日： 2003-07-25
-
公开(公告)号： US07612075B2公开(公告)日： 2009-11-03
- 发明人: William R. Ewing , Michael R. Becker , Yong Mi Choi-Sledeski , Heinz W. Pauls , Wei He , Stephen M. Condon , Roderick S. Davis , Barbara A. Hanney , Alfred P. Spada , Christopher J. Burns , John Z. Jiang , Michael R. Myers , Wan F. Lau , Aiwen Li , Gregory B. Poli , Mark A. Bobko , Robert L. Morris , Joseph M. Karpinski , Timothy F. Gallagher , Kent W. Neuenschwander , Robert D. Groneberg , Jean-Francois Sabuco
- 申请人： William R. Ewing , Michael R. Becker , Yong Mi Choi-Sledeski , Heinz W. Pauls , Wei He , Stephen M. Condon , Roderick S. Davis , Barbara A. Hanney , Alfred P. Spada , Christopher J. Burns , John Z. Jiang , Michael R. Myers , Wan F. Lau , Aiwen Li , Gregory B. Poli , Mark A. Bobko , Robert L. Morris , Joseph M. Karpinski , Timothy F. Gallagher , Kent W. Neuenschwander , Robert D. Groneberg , Jean-Francois Sabuco
- 申请人地址： US NJ Bridgewater
- 专利权人： Aventis Pharmaceuticals Inc.
- 当前专利权人： Aventis Pharmaceuticals Inc.
- 当前专利权人地址： US NJ Bridgewater
- 代理商 Ronald G. Ort; Jiang Lin
- 主分类号： A61K31/497
- IPC分类号： A61K31/497 ; C07D401/06
摘要：
This invention is directed to oxoazaheterocycyl compounds which inhibit Factor Xa, to oxoazaheterocycyl compounds which inhibit both Factor Xa and Factor IIa, to pharmaceutical compositions comprising these compounds, to intermediates useful for preparing these compounds, to a method of directly inhibiting Factor Xa and to a method of simultaneously directly inhibiting Factor Xa and Factor IIa.
公开/授权文献
- US20040102450A1 Substituted oxoazaheterocyclyl compounds 公开/授权日：2004-05-27
信息查询
IPC分类:
